Company Filing History:
Years Active: 1999-2000
Title: The Innovative Contributions of Jose Mario Garcia
Introduction
Jose Mario Garcia is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic applications. With a total of 2 patents, his work has the potential to impact various medical fields.
Latest Patents
One of his latest patents involves the development of agonist and antagonist antibodies to the chemokine receptor-2 (CCR2). This invention relates to antibodies capable of binding to the monocyte chemoattractant protein 1 (MCP-1) receptor CCR2. These antibodies can act as either antagonists or agonists and are useful for in vitro and in vivo diagnostics. They can be employed for screening and detecting tissues and classes of cells that express the MCP-1 receptor, as well as for screening new drugs and therapeutic applications. Additionally, the invention includes a preparation comprising the claimed antibody and a microorganism or cell line capable of producing it.
Another significant patent by Garcia is a monoclonal antibody that specifically binds to the 20 kDa variant of human growth hormone (hGH). This monoclonal antibody does not substantially bind to the 22 kDa variant of hGH. The invention is particularly useful for measuring hGH 20K in body fluids, allowing for the detection and quantification of this variant, especially in serum.
Career Highlights
Throughout his career, Jose Mario Garcia has worked with prominent organizations such as Pharmacia & Upjohn and the Consejo Superior de Investigaciones Científicas. His experience in these institutions has contributed to his expertise in the field of biotechnology and antibody development.
Collaborations
Garcia has collaborated with notable colleagues, including Carlos Martinez Alonso and Jose Miguel Frade. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Jose Mario Garcia's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work on antibodies has the potential to lead to significant advancements in diagnostics and therapeutics.